Precision of liver and pancreas apparent diffusion coefficients using motion-compensated gradient waveforms in DWI
- PMID: 38641212
- PMCID: PMC11098682
- DOI: 10.1016/j.mri.2024.04.026
Precision of liver and pancreas apparent diffusion coefficients using motion-compensated gradient waveforms in DWI
Abstract
Background: Diffusion weighted imaging (DWI) with optimized motion-compensated gradient waveforms reduces signal dropouts in the liver and pancreas caused by cardiovascular-associated motion, however its precision is unknown. We hypothesized that DWI with motion-compensated DW gradient waveforms would improve apparent diffusion coefficient (ADC)-repeatability and inter-reader reproducibility compared to conventional DWI in these organs.
Methods: In this IRB-approved, prospective, single center study, subjects recruited between October 2019 and March 2020 were scanned twice on a 3 T scanner, with repositioning between test and retest. Each scan included two respiratory-triggered DWI series with comparable acquisition time: 1) conventional (monopolar) 2) motion- compensated diffusion gradients. Three readers measured ADC values. One-way ANOVA, Bland-Altman analysis were used for statistical analysis.
Results: Eight healthy participants (4 male/4 female), with a mean age of 29 ± 4 years, underwent the liver and pancreas MRI protocol. Four patients with liver metastases (2 male/2 female) with a mean age of 58 ± 5 years underwent the liver MRI protocol. In healthy participants, motion-compensated DWI outperformed conventional DWI with mean repeatability coefficient of 0.14 × 10-3 (CI:0.12-0.17) vs. 0.31 × 10-3 (CI:0.27-0.37) mm2/s for liver, and 0.11 × 10-3 (CI:0.08-0.15) vs. 0.34 × 10-3 (CI:0.27-0.49) mm2/s for pancreas; and with mean reproducibility coefficient of 0.20 × 10-3 (CI:0.18-0.23) vs. 0.51 × 10-3 (CI:0.46-0.58) mm2/s for liver, and 0.16 × 10-3 (CI:0.13-0.20) vs. 0.42 × 10-3 (CI:0.34-0.52) mm2/s for pancreas. In patients, improved repeatability was observed for motion-compensated DWI in comparison to conventional with repeatability coefficient of 0.51 × 10- 3 mm2/s (CI:0.35-0.89) vs. 0.70 × 10-3 mm2/s (CI:0.49-1.20).
Conclusion: Motion-compensated DWI enhances the precision of ADC measurements in the liver and pancreas compared to conventional DWI.
Keywords: ADC; DWI; Liver; Pancreas; Repeatability.
Copyright © 2024 Elsevier Inc. All rights reserved.
Figures








Similar articles
-
Quantifying multi-institutional ADC measurement variability of 1.5 T MR-Linacs: A phantom and in vivo study.Med Phys. 2025 Jun;52(6):4120-4133. doi: 10.1002/mp.17739. Epub 2025 Mar 13. Med Phys. 2025. PMID: 40079445 Free PMC article.
-
Diagnostic Utility of Diffusion-Weighted MRI and Apparent Diffusion Coefficient Values in Differentiating Metastatic From Non-metastatic Lymph Nodes in Cervical Carcinoma.Cureus. 2025 Jun 4;17(6):e85371. doi: 10.7759/cureus.85371. eCollection 2025 Jun. Cureus. 2025. PMID: 40621327 Free PMC article.
-
Self-supervised denoising diffusion probabilistic models for abdominal DW-MRI.Magn Reson Med. 2025 Sep;94(3):1284-1300. doi: 10.1002/mrm.30536. Epub 2025 May 1. Magn Reson Med. 2025. PMID: 40312927
-
Accuracy of quantitative diffusion-weighted imaging for differentiating benign and malignant pancreatic lesions: a systematic review and meta-analysis.Eur Radiol. 2021 Oct;31(10):7746-7759. doi: 10.1007/s00330-021-07880-3. Epub 2021 Apr 13. Eur Radiol. 2021. PMID: 33847811
-
Diffusion-weighted MRI for predicting and assessing treatment response of liver metastases from CRC - A systematic review and meta-analysis.Eur J Radiol. 2023 Jun;163:110810. doi: 10.1016/j.ejrad.2023.110810. Epub 2023 Apr 7. Eur J Radiol. 2023. PMID: 37075628
References
-
- Niwa T, Ueno M, Ohkawa S, Yoshida T, Doiuchi T, Ito K, et al. Advanced pancreatic cancer: the use of the apparent diffusion coefficient to predict response to chemotherapy. Br J Radiol. 2009;82:28–34. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources